gemcitabine has been researched along with neurotensin in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bracci, L; Brunetti, J; Carini, M; Depau, L; Falciani, C; Lelli, B; Menichetti, S; Minervini, A; Pini, A; Ravenni, N; Siena, G; Tenori, E | 1 |
1 other study(ies) available for gemcitabine and neurotensin
| Article | Year |
|---|---|
Neurotensin branched peptide as a tumor-targeting agent for human bladder cancer.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Biopsy; Cell Death; Cell Line, Tumor; Deoxycytidine; Endocytosis; Female; Fluorescence; Gemcitabine; Humans; Male; Methotrexate; Middle Aged; Neurotensin; Protein Binding; Urinary Bladder Neoplasms | 2015 |